A Manhattan art dealer who claims to be related to a famed family allegedly left his Swiss wedding planner on the hook for ...
Guggenheim has initiated its coverage of psychedelic drug developer Cybin (NYSE:CYBN) with a Buy rating and a $35 per share ...
Danny Guggenheim, a member of Mintz's Los Angeles Real Estate Group since 2020, also serves as co-chair of the international ...
DICK’S Sporting Goods (NYSE:DKS – Get Free Report)‘s stock had its “neutral” rating reiterated by equities research analysts at Guggenheim in a research note issued on Wednesday,Benzinga reports.
Mintz’s Los Angeles Real Estate Group as a member in October 2020. He was previously a partner in the Real Estate Group at ...
Fintel reports that on March 13, 2025, Guggenheim initiated coverage of Cybin (NYSEAM:CYBN) with a Buy recommendation.
Art dealer Gordon VeneKlasen abhors censorship but concedes that China represents a huge, still untapped market: “Asia is a ...
Desert Furs performance: 5:30 p.m. Saturday, Left Hand Brewing, 1265 Boston Ave., Longmont. Get stoked for a day of stouts, ...
Immersive AI Art installation created by Turkish Artist Refik Anadol pays homage to Architect Frank Gehry in inaugural 'in ...
One reason Tesla investors should sell into the stock’s recent bounce is because of all the “political noise” surrounding ...
Guggenheim initiated coverage of Cybin (CYBN) with a Buy rating and $35 price target Light Up your Portfolio with Spark:Easily identify stocks' ...
Guggenheim raised the firm’s price target on AnaptysBio (ANAB) to $52 from $36 and keeps a Buy rating on the shares following the company’s Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results